Integrative Analysis of Response to Tamoxifen Treatment in ER-Positive Breast Cancer Using GWAS Information and Transcription Profiling.

Breast Cancer (Auckl) · 2012 · PMC3292850 · PMID 22399860

Europe PMC DOI

hedged sentence

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantP < 0.000001actually significant

After ranking the genes in the test and validation sets, we identified a signature of 95 highly significant ( P < 0.000001) differentially expressed genes (FDR = 0), which distinguished tamoxifen treated from untreated breast cancer patients ( Fig. 3 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.